AzTrials
AzTrials

AmblyopiaPhase 1NCT00097162

Visual Cortex Stimulation in Patients With Amblyopia

A Phase 1 study testing Anodal stimulation in people with Amblyopia and Anisometropic Ambyopia, run by National Eye Institute (NEI) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will examine whether direct current (DC) polarization (electrical stimulation) of the visual cortex can cause a temporary improvement of vision in an amblyopic eye of an adult. Amblyopia (also called lazy eye) is reduced vision in an eye, caused by abnormal brain processing of visual information. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Anodal stimulation
Type of treatment
Surgery or procedure
How many people
10 participants
Where
1 siteUnited States
Study dates
Nov 2004to Jun 2006
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Amblyopia as defined by at least 2 logMAR units difference in the visual acuity between the two eyes as measured by ETDRS chart
  • VA in the sound eye 20/40 or better
  • VA in amblyopic eye 20/40-20/400
  • Amblyopia due to anisometropia, strabismus or both
  • No ocular cause of reduced VA and no prior ocular surgery

Who cannot join

  • Deprivation amblyopia
  • Structural ocular disease or prior ocular trauma/surgery
  • Current serious medical or psychiatric condition of any kind
  • History of any significant trauma or medical condition affecting the brain or skull
  • History of epileptic seizure
  • History of significant psychiatric illness, i.e., requiring medication or hospitalization
Show all 11Show fewer
  • Current use of neuroactive medication or recreational drugs
  • Pregnancy
  • Presence of metal in the head other than dental hardware
  • Broken skin in the area of the stimulating electrodes
  • Presence of implantable pacemaker or defibrillator

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Eye Institute (NEI)

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia

This study will examine whether direct current (DC) polarization (electrical stimulation) of the visual cortex can cause a temporary improvement of vision in an amblyopic eye of an adult. Amblyopia (also called lazy eye) is reduced vision in an eye, caused by abnormal brain processing of visual information. In amblyopia, the visual cortex (the part of the brain that processes visual information) favors the other eye and suppresses the image from the amblyopic eye.

Amblyopia in children is treated by patching or blurring the good eye, which forces the child to use the amblyopic eye and overcome suppression by the brain. This treatment only works in children 8 years old and younger, however. Electrical stimulation of the brain can temporarily change the function of the visual cortex in adults with good vision, but its influence on the visual function of people with amblyopia is unknown. If DC polarization can improve vision in amblyopic eyes in adults, it would show that the visual cortex is still plastic, and it might help researchers develop a treatment for adults with amblyopia in the future.

Read more

Patients 18 years of age and older with amblyopia caused by crossing in or turning out of the eyes in childhood or by a difference in near- or farsightedness between the eyes may be eligible for this study. Candidates are screened with a medical history and complete eye examination, including a glaucoma screening and checks of vision, in- or out-turning of the eyes, depth perception, need for glasses, and the interior structures of the eyes.

Participants undergo two study sessions, scheduled at least 24 hours apart, involving the following procedures:

  • Examination: Before each session, the patients' distance vision, contrast sensitivity (ability to see fading letters), and ability to read small print are checked in both eyes.
  • DC polarization: Patients receive either 20 minutes of electrical stimulation or 20 minutes of sham stimulation (each patient will receive both electrical and sham stimulation on different days).
  • Repeat examination: Immediately after the stimulation and again 20 minutes later, patients undergo repeat visual function testing. Those who show any differences in visual function 20 minutes after the stimulation are examined again 1 hour after the stimulation. Patients in whom the effect continues after 1 hour are examined again after 1 week.
Read the detailed description

Background: Amblyopia is a disorder of reduced visual function in an eye, without ocular disease, which arises as a result of an abnormal visual experience in early life. It is attributed to a cortical suppression of the image from the amblyopic eye caused by blur or diplopia. Amblyopia is the leading cause of preventable monocular vision loss in the US affecting 2% to 5% of the population. In addition to significant visual deficits, amblyopes are more likely to loose sight in the other, healthy eye as a result of accidents or ocular diseases. Accepted treatment of amblyopia, which includes patching or pharmacological, or optical penalization of the fellow eye, is limited to young children. This treatment is considered ineffective beyond 8 years of age, and no treatment is offered to older individuals, who comprise 72% of the population of amblyopes.

Recent evidence suggests that some cortical plasticity might be present in older individuals beyond the accepted age limit for the amblyopia treatment. Spontaneous improvement of visual acuity in the amblyopic eye was reported in some adults, who lost sight in the good eye following trauma or disease. However, the chance of spontaneous improvement of visual acuity to a usable level is relatively low. Therefore, it is important to search for modalities to improve the vision in amblyopic individuals to prevent incapacitating loss of function following loss of sight in a sound eye.

Weak direct current (DC) stimulation is a noninvasive method able to induce cortical excitability changes. It has been previously safely applied in many animal and several human studies, and was able to modulate activity of primary motor and prefrontal cortices. These studies revealed that cathodal stimulation reduces spontaneous firing rates of cortical cells, most likely by hyperpolarizing cortical neurons, whereas anodal stimulation results in a reverse effect. The number of studies applying DC stimulation over the human visual cortex is still limited, however these have shown that DC stimulation can induce modulation in the excitability of the visual cortex, similar to what was observed in motor and prefrontal cortex. This modulation is reflected by changes in both psychophysical and electrophysiological parameters of normal volunteers. Because DC stimulation can induce acute, as well as prolonged modulation in the cortical excitability and activity, it could be employed as a tool for studying neuroplasticity, and might be beneficial in conditions accompanied by pathological changes in cortical excitability, such as amblyopia.

In the proposed study we will assess a short-term effect of DC stimulation of the occipital cortex on the visual function of 10 adult amblyopic subjects. If the study will demonstrate a favorable effect, then DC stimulation could be used in the future to induce lasting benefits in amblyopes, because the duration of the after-effects depend on the duration, intensity, and polarity of stimulation.

Aims: To gather preliminary data on whether DC stimulation of the occipital cortex can modulate visual function in adult amblyopic subjects. We will check the short-term effect of the DC stimulation on the plasticity of the visual cortex and its ability to temporarily alter the impaired visual functions in amblyopia.

To confirm on amblyopic adults that DC stimulation of the visual cortex is safe and well tolerated, similar to what has been previously established on normal volunteers.

Methods: In the current study we plan to enroll 10 amblyopic subjects ages 18 and older. Based on the previous reports, anodal stimulation has an excitatory effect, and cathodal stimulation has an inhibitory effect on the cortex. Therefore, only anodal stimulation of the visual cortex will be performed on the amblyopic subjects. The stimulation will be applied over the occipital cortex, duration 20 min at 2mA. As a placebo, a sham stimulation of the same duration will be applied on the same area of the scalp of all subjects at least 24 hours before or after the anodal stimulation, in a random order. The stimulation will be done in the masked fashion, so that neither the study subjects, nor the investigator assessing their visual function will be aware of the type of stimulation.

Assessment of visual function will be done before, and immediately and 20 min after the DC stimulation, and will include measuring visual acuity, contrast sensitivity, reading speed and reading acuity. In each session both amblyopic and fellow eye will be assessed starting with the amblyopic eye. If any differences from the pre-stimulation visual function will be detected 20 min after the stimulation, the patients will also be examined 1 hour after the stimulation and, if the effect persists, 1 week following that.

Being tested
Anodal stimulation
Keywords
Anisometropia, Strabismus, Cortical Suppression, Impaired Vision, Cortical Plasticity, Amblyopia, Adult Amblyopia
Medical subject headings
Amblyopia, Anisometropia, Strabismus, Vision Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anodal stimulationProcedure or surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2004 (estimated)
  2. Study startNov 2004
  3. Study completionJun 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Enrolment
10 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00097162
Sponsor's protocol ID
050005
Other IDs
05-EI-0005
Status last verified
Jun 2006
First submitted
17 Nov 2004
Last updated
26 Jun 2006
Results posted
No

Publications

  • Antal A, Nitsche MA, Paulus W. External modulation of visual perception in humans. Neuroreport. 2001 Nov 16;12(16):3553-5. doi: 10.1097/00001756-200111160-00036.

    PubMed 11733710

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Anodal stimulation in people with Amblyopia and Anisometropic Ambyopia, run by National Eye Institute (NEI) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00097162, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2006.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in